|
|
|
Date:
|
|
Wednesday, May 15
th
, 2019
|
Time:
|
|
10:30 a.m. Eastern Time | 8:30 a.m. Mountain Time
|
Webcast:
|
|
https://bit.ly/2GRpDP3
|
Replay:
|
|
(416)
849-0833
or (855)
859-2056
|
|
|
until 12:00 midnight Eastern Time Wednesday, May 22, 2019
|
Reference Number:
|
|
1103129
|
|
(1)
|
Non-IFRS
measures are defined in the companys MD&A.
|
About Aurora
Headquartered in
Edmonton, Alberta, Canada with funded capacity in excess of 625,000 kg per annum and sales and operations in 24 countries across five continents, Aurora is one of the worlds largest and leading cannabis companies. Aurora is vertically
integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high
value-add
product development, home cultivation, wholesale and retail distribution.
Highly differentiated from
its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization,
resulting in the massive scale production of high-quality product at low cost. Intended to be replicable and scalable globally, our production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading
yields, and low per gram production costs. Each of Auroras facilities is built to meet EU GMP standards. EU GMP certification has been granted to Auroras first production facility in Mountain View County, the MedReleaf Markham facility,
and its wholly owned European medical cannabis distributor Aurora Deutschland.
In addition to the Companys rapid organic growth and strong
execution on strategic M&A, which to date includes 16 wholly owned subsidiary companies MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed
Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, and Chemi Pharmaceutical Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having
invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM),
Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), High Tide Inc. (CSE: HITI) and EnWave Corporate (TSXV: ENW).
Page | 9